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COMMENTARY
Healthy obesity: time to give up the ghost?
William Johnson
School of Sport, Exercise and Health Sciences, Loughborough University, Leicestershire, UK
The notion that it is possible to be obese yet have no cardio-
metabolic complications (e.g. dyslipidaemia and hyperinsuli-
nemia) is attractive to those of us whose body mass index
(BMI) has crossed the threshold of 30 kg/m2. However, since
the first reports of so-called ‘metabolically healthy obesity’ in
the 1980s, numerous studies have shown that such individu-
als (1) can be rare, depending on the population and diag-
nostic criteria, (2) transition to being unhealthy more
frequently than their non-obese counterparts and (3) have
increased risk of various non-communicable diseases (e.g.
type 2 diabetes and chronic kidney disease) and higher mor-
tality compared to healthy normal-weight individuals.
Literature on the third point has been summarised in system-
atic reviews and meta-analyses, most of which have reached
the same conclusion that healthy obesity is not benign.
Despite the strength of this evidence, large-scale epidemio-
logical studies are still frequently published on healthy obes-
ity and disease/mortality risk in leading cardiovascular
medicine journals. In September 2017, for example, the
Journal of the American College of Cardiology (SJR 2016—
11.488; impact factor 2017—19.896) published an analysis
among 3.5 million adults, finding that healthy obese individu-
als had higher risk for incident cardiovascular disease events
than their healthy normal weight peers (Caleyachetty et al.,
2017). Naturally, the media have a field day in spinning these
types of findings; the BBC news, in this instance, going with
‘Fat but fit is a big fat myth’, despite the study not looking
at fitness (BBC, 2017).
What is less well-understood, or at least acknowledged, is
why studies find increased disease/mortality risk in healthy
obese individuals. As one might expect, individuals who are
obese yet healthy are more likely to be younger, of European
ancestry, lead a healthier lifestyle in terms of physical activity
and diet, etc., have less central and visceral adiposity and be
of higher socio-economic position than obese individuals
who have already developed complications. The opposite is
true (e.g. more likely to be older, non-European ancestry,
lead an unhealthier lifestyle, etc.) when compared against a
healthy normal-weight group. Thus, it probably comes as no
surprise that levels of cardio-metabolic disease risk factors
(e.g. systolic blood pressure and fasting glucose) are worse
among healthy obese than healthy normal weight individu-
als, despite both groups having the same label of ‘healthy’.
The vast majority of studies report these systematic differen-
ces in an initial descriptive statistics table, but then go on to
conduct inferential analyses that ignore them. The problem
arises from crudely dichotomising continuous variables to
define weight and health status. For example, with a BMI
cut-off of 30 kg/m2 and a blood pressure cut-off of 140/
90mmHg, both an obese person with blood pressure of 139/
89 and a non-obese person with blood pressure of 110/70
would be classified as healthy. The fact that healthy obese
individuals are actually less healthy on average than healthy
normal weight individuals is intuitive and must, at least
partly, explain why disease or mortality risk differs between
the two groups. Documented associations of healthy obesity
with disease or mortality risk might, therefore, be viewed as
a self-fulfilling prophecy.
There is, of course, the argument that the concept of
healthy obesity is clinically motivated, because it allows doc-
tors to easily stratify the growing population of obese adults
into those who most urgently require treatment and those
who do not. Risks of disease and death are substantially
lower among healthy obese individuals than unhealthy obese
individuals, so targeting pharmacological and lifestyle inter-
ventions at the latter group would seem prudent given pres-
sures on national health services. This must already happen
to some extent in some healthcare settings. Nonetheless, an
initial target of transitioning from an unhealthy to healthy
cardio-metabolic profile, without necessarily losing a lot of
body weight, has been described by Stefan et al. (2018) as
the ‘low-hanging fruit’ in obesity treatment. As nicely sur-
mised in their Lancet Diabetes and Endocrinology series paper,
there is, however, limited evidence on which interventions
would have this desired effect and there are various other
hurdles to overcome before such a strategy could be imple-
mented as standard care. One of these is agreeing on a uni-
versally accepted diagnosis for metabolic health; the
conundrum being that existing binary definitions do not
have great accuracy for predicting disease risk. Any interven-
tion targeted solely at the unhealthy obese population
would, therefore, miss many other ‘high risk’ individuals, not
least those who are unhealthy but not obese.
The future of healthy obesity research might seem bleak
from the picture I have painted, but it shouldn’t. The idea
that different sub-groups of a population can have similar
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BMI values (and even similar levels of adiposity) but different
cardio-metabolic disease risk factor profiles is both statistic-
ally credible, given rules of multivariate normal distributions,
and biologically plausible (e.g. as an example of one mechan-
ism, the same allele in a genetic variant near ISR1 is related
to both increased percentage body fat and decreased insulin
resistance, dyslipidemia and risk of type 2 diabetes and cor-
onary heart disease (Kilpelainen et al., 2011)). In my mind,
however, the very construct of healthy obesity has led to a
plethora of epidemiological research and debate on whether
or not the phenomenon truly exists, instead of asking ques-
tions that accept, exploit and investigate heterogeneity
among people with the same BMI. When viewed this way,
there are many novel and important research questions that
human biologists might see as being better aligned with
their field. In particular, we know very little about the bio-
logical processes and mechanisms (e.g. growth and develop-
ment patterns) and modifiable lifestyle factors (e.g. physical
activity and diet), operating across the life course, that lead
to some people developing a disease or dying while other
people with the same BMI do not. Such research would help
develop targeted prevention programmes, in line with vari-
ous precision or stratified medicine initiatives, such as that of
the UK Medical Research Council (MRC, 2010).
It is undeniable that obesity is bad for health, but there
are clearly differences between individuals in the extent to
which it is bad. While the concept of healthy obesity is crude
and problematic and may best be laid to rest, there is great
opportunity for human biological investigation of the levels,
causes and consequences of heterogeneity in health among
people with the same BMI.
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